These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22820178)

  • 1. How therapeutic communities work: specific factors related to positive outcome.
    Pearce S; Pickard H
    Int J Soc Psychiatry; 2013 Nov; 59(7):636-45. PubMed ID: 22820178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The availability of integrated care in a national sample of therapeutic communities.
    Dye MH; Roman PM; Knudsen HK; Johnson JA
    J Behav Health Serv Res; 2012 Jan; 39(1):17-27. PubMed ID: 21744180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saudi addiction therapeutic communities:Are they implementing the essential elements of addiction therapeutic communities.
    Alshomrani AT
    Neurosciences (Riyadh); 2016 Jul; 21(3):227-31. PubMed ID: 27356653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are prison-based therapeutic communities effective? Challenges and considerations.
    Richardson J; Zini V
    Int J Prison Health; 2020 Dec; 17(1):42-53. PubMed ID: 33634656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic communities for substance related disorder.
    Smith LA; Gates S; Foxcroft D
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005338. PubMed ID: 16437526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic communities for addictions: a review of their effectiveness from a recovery-oriented perspective.
    Vanderplasschen W; Colpaert K; Autrique M; Rapp RC; Pearce S; Broekaert E; Vandevelde S
    ScientificWorldJournal; 2013; 2013():427817. PubMed ID: 23401669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The success of therapeutic communities for substance abusers in American prisons.
    Wexler HK
    J Psychoactive Drugs; 1995; 27(1):57-66. PubMed ID: 7602441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopathology and substance abuse: what is being learned from research in therapeutic communities.
    De Leon G
    J Psychoactive Drugs; 1989; 21(2):177-88. PubMed ID: 2668482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of therapeutic communities: a systematic review.
    Malivert M; Fatséas M; Denis C; Langlois E; Auriacombe M
    Eur Addict Res; 2012; 18(1):1-11. PubMed ID: 21997500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Intensity Transcranial Current Stimulation in Psychiatry.
    Philip NS; Nelson BG; Frohlich F; Lim KO; Widge AS; Carpenter LL
    Am J Psychiatry; 2017 Jul; 174(7):628-639. PubMed ID: 28231716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of psychiatric comorbidity on the in-treatment outcomes of cocaine-dependent patients in therapeutic communities.
    González-Saiz F; Vergara-Moragues E; Verdejo-García A; Fernández-Calderón F; Lozano OM
    Subst Abus; 2014; 35(2):133-40. PubMed ID: 24821349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the use of therapeutic communities with sexual offenders.
    Ware J; Frost A; Hoy A
    Int J Offender Ther Comp Criminol; 2010 Oct; 54(5):721-42. PubMed ID: 19666834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight across mental disorders: A multifaceted metacognitive phenomenon.
    Konstantakopoulos G
    Psychiatriki; 2019; 30(1):13-16. PubMed ID: 31115349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic communities for addictions: a theoretical framework.
    De Leon G
    Int J Addict; 1995; 30(12):1603-45. PubMed ID: 8557410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residential therapeutic communities in the mainstream: diversity and issues.
    De Leon G
    J Psychoactive Drugs; 1995; 27(1):3-15. PubMed ID: 7602438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population].
    Zanello A; Weber Rouget B; Gex-Fabry M; Maercker A; Guimon J
    Encephale; 2006; 32(1 Pt 1):45-59. PubMed ID: 16633290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles of substance use disorders in patients of therapeutic communities: link to social, medical and psychiatric characteristics.
    Fernández-Calderón D; Fernández F; Ruiz-Curado S; Verdejo-García A; Lozano ÓM
    Drug Alcohol Depend; 2015 Apr; 149():31-9. PubMed ID: 25682479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mental health improvements of substance-dependent clients after 4 months in a Therapeutic Community.
    Polimeni AM; Moore SM; Gruenert S
    Drug Alcohol Rev; 2010 Sep; 29(5):546-50. PubMed ID: 20887579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.